ANDREA BOWDEN: Open Payments
NPI 1871006510 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 37 payments from 11 companies in 2025. Trend: 2023 $1,320 · 2024 $876 · 2025 $819
Food & beverage: $723Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $263 |
| ABBVIE INC. | 6 | $192 |
| PFIZER INC. | 5 | $92 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Amgen Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $53 |
| UCB, Inc. | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
| GENZYME CORPORATION | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: DUPIXENT, RINVOQ, CIBINQO, Zoryve, OTEZLA, TALTZ, SKYRIZI, Bimzelx.
Industry payments across TX — which companies pay providers there.
